USD Biomedical Engineering Faculty Receive I-Corps Team Award from NSF
The award funds an innovative technology named the Resource Enhancement and Advanced Discovery System (READS) designed to assist users in locating the most relevant analytic tools and data using natural language capabilities.
The patent-pending technology will allow end-users to discover, reuse, validate, share and exchange knowledge related to data and analytic tools, which will greatly enhance users’ ability to answer challenging questions. The USD team is currently focusing on customizing this tool for geoscientists, financial analysts and biotechnologists.
The I-Corps Teams Program grant is designed to assist the university’s researchers in developing a focus beyond their academic laboratories, and is intended to advance the economic benefits of NSF-funded research by transitioning science to the marketplace.
Assisting Gnimpieba and Lushbough will include a team of two student entrepreneur leads, Riley Paulsen and Tayler Hoekstra, and a business mentor Kevin Hildring. This work is also being supported by the new non-profit group called the Dakota Research and Consulting Organization or DRACO for management and business development.
You May Also Like
Two undergraduate researchers from the University of South Dakota will present at the 2021 South Dakota Student Research Poster Session March 3. Morgan Eikanger and Tim Hartman will display their posters in the Rotunda of the South Dakota State Capitol and present their research to state legislators and other state officials in South Dakota.
Eric Sandhurst '08 B.S., '16 M.S., '20 Ph.D., president and founding partner of the Dakota Research and Consulting Organization (DRACO), discussed entrepreneurship and the future of biotechnology in South Dakota on Credit Hour.
University of South Dakota researcher and assistant professor in the biomedical engineering program, Zhongkui Hong, Ph.D., has received a grant from the National Institute of Health (NIH) for his research in combatting atherosclerosis and its role as one of the leading causes of global death. Hong’s lab will use the grant to run three different tests to observe adhesion, migration and phenotypic shifting of vascular smooth muscle cells (VSMCs) and how it plays a key role in the progression of this cholesterol-associated disease.